How to address smoking cessation in HIV patients

HIV Medicine

Volumn 16, Issue 4, 2015, Pages 201-210

  Calvo Sanchez M ^a,b   Martinez, E ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cessation; HIV; Smoking

Indexed keywords

ABACAVIR; AMFEBUTAMONE; CLONIDINE; ELECTRONIC CIGARETTE; LINEZOLID; NICOTINE GUM; NICOTINE PATCH; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; NORTRIPTYLINE; PROTEINASE INHIBITOR; RITONAVIR; VARENICLINE;

AIDS PATIENT; AVERSION THERAPY; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DEPRESSION; DRUG CONTRAINDICATION; FOLLOW UP; GROUP THERAPY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; MEDICAL STAFF; MEDLINE; MENTAL DISEASE; MOOD DISORDER; MOTIVATION; NICOTINE REPLACEMENT THERAPY; NONHUMAN; NURSING STAFF; PATIENT ATTITUDE; PATIENT COUNSELING; PHYSICIAN; POLYPHARMACY; PRACTICE GUIDELINE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEIZURE; SEIZURE THRESHOLD; SEROTONIN SYNDROME; SEXUALLY TRANSMITTED DISEASE; SMOKING; SMOKING CESSATION; SOCIAL STIGMA; SUICIDAL IDEATION; TOBACCO CONSUMPTION; TOBACCO DEPENDENCE; TOBACCO USE; UNEMPLOYMENT; WEIGHT GAIN; ADVERSE EFFECTS; ATTITUDE TO HEALTH; DIRECTIVE COUNSELING; DOCTOR PATIENT RELATION; HEALTH PROMOTION; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RISK FACTOR; TOBACCO USE DISORDER;

DIRECTIVE COUNSELING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HIV INFECTIONS; HUMANS; MOTIVATION; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER;

EID: 84924742584     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12193     Document Type: Review

References (83)

1. Rahmanian S, Wewers ME, Koletar S, Reynolds N, Ferketich A, Diaz P. Cigarette smoking in the HIV-infected population. Proc Am Thorac Soc 2011; 8: 313-319.
2. Lifson AR, Lando HA. Smoking and HIV: prevalence, health risks, and cessation strategies. Curr HIV/AIDS Rep 2012; 9: 223-230.
3. Helleberg M, Gerstoft J, Afzal S, Kronborg G, Cs L, Se B. Impact of smoking on risk of cancer among HIV patients compared to the background population. Conference on Retroviruses and Opportunistic Infections. Boston, MA, March 2014 P-02 553.
4. Helleberg M, May M, Ingle S, Dabis F, Reiss P, Fätkenheuer G. Impact of smoking on life expectancy among HIV-infected individuals?: the ART Cohort Collaboration on Behalf of the Antiretroviral Therapy Cohort Collaboration (ART-CC). Conference on Retroviruses and Opportunistic Infections. Boston, MA, March 2014 Poster 559.
5. Bernard A, Bonnet F, Tessier JF, Fossoux H, Dupon M. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDS 2007; 21: 458-468.
6. Gritz ER, Vidrine DJ, Lazev AB, Amick BC, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 2004; 6: 71-77.
7. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res 2005; 7: 511-522.
8. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDS 2002; 16: 39-42.
9. Messer K, Trinidad DR, Al-Delaimy WK, Pierce JP. Smoking cessation rates in the United States: a comparison of young adult and older smokers. Am J Public Health 2008; 98: 317-322.
10. Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav 2009; 13: 545-554.
11. CDC C for DC and P. Smoking and Tobacco Use. 2014 surgeon general's report: the health consequences of smoking - 50 years of progress. Atlanta, 2014. Available at http://www.cdc.gov/tobacco/data_statistics/sgr/50th-anniversary/index.htm (accessed 15 Mar 2014).
12. Jha P, Ramasundarahettige C, Landsman V etal. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 2013; 368: 341-350.
13. Gellert C, Schöttker B, Müller H, Holleczek B, Brenner H. Impact of smoking and quitting on cardiovascular outcomes and risk advancement periods among older adults. Eur J Epidemiol 2013; 28: 649-658.
14. Clair C, Rigotti NA, Porneala B etal. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA 2013; 309: 1014-1021.
15. Lietz M, Berges A, Lebrun S etal. Cigarette-smoke-induced atherogenic lipid profiles in plasma and vascular tissue of apolipoprotein E-deficient mice are attenuated by smoking cessation. Atherosclerosis 2013; 229: 86-93.
16. Kondo T, Hayashi M, Takeshita K etal. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004; 24: 1442-1447.
17. Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TRH. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health 2010; 100: 1896-1903.
18. Vidrine DJ, Arduino RC, Gritz ER. The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care STDS 2007; 21: 659-666.
19. Petoumenos K, Worm S, Reiss P etal. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study. HIV Med 2011; 12: 412-421.
20. De P, Farley A, Lindson N, Aveyard P. Systematic review and meta-analysis: influence of smoking cessation on incidence of pneumonia in HIV. BMC Med 2013; 11: 15.
21. Winhusen TM, Kropp F, Theobald J, Lewis DF. Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment. Drug Alcohol Depend 2014; 134: 391-395.
22. Shirley DK, Kesari RK, Glesby MJ. Factors associated with smoking in HIV-infected patients and potential barriers to cessation. AIDS Patient Care STDS 2013; 27: 604-612.
23. Grover KW, Gonzalez A, Zvolensky MJ. HIV symptom distress and smoking outcome expectancies among HIV+ smokers: a pilot test. AIDS Patient Care STDS 2013; 27: 17-21.
24. Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr 2006; 42: 298-306.
25. Nicholas PK, Voss JG, Corless IB etal. Unhealthy behaviours for self-management of HIV-related peripheral neuropathy. AIDS Care 2007; 19: 1266-1273.
26. Leserman J, Ironson G, O'Cleirigh C, Fordiani JM, Balbin E. Stressful life events and adherence in HIV. AIDS Patient Care STDS 2008; 22: 403-411.
27. Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res 2008; 10: 731-736.
28. Fingeret MC, Vidrine DJ, Arduino RC, Gritz ER. The association between body image and smoking cessation among individuals living with HIV/AIDS. Body Image 2007; 4: 201-206.
29. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term wieght gain in women and men. N Engl J Med 2011; 364: 2392-2404.
30. Tamí-Maury I, Vidrine D, Fletcher F, Danysh H, Arduino R, Gritz E. Poly-tobacco use among HIV-positive smokers: implications for smoking cessation efforts. Nicotine Tob Res 2013; 15: 2100-2106.
31. Nahvi S, Cooperman NA. Review: the need for smoking cessation among HIV-positive smokers. AIDS Educ Prev 2009; 21: 14-27.
32. Browning KK, Ferketich AK, Salsberry PJ, Wewers ME. Socioeconomic disparity in provider-delivered assistance to quit smoking. Nicotine Tob Res 2008; 10: 55-61.
33. Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med 2007; 30: 371-383.
34. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav 2010; 14: 824-835.
35. Crothers K, Goulet JL, Rodriguez-Barradas MC etal. Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med 2007; 22: 749-754.
36. Feldman JG, Minkoff H, Schneider MF etal. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health 2006; 96: 1060-1065.
37. Friis-Møller N, Sabin CA, Weber R etal. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349: 1993-2003.
38. Depairon M, Chessex S, Sudre P etal. Premature atherosclerosis in HIV-infected individuals-focus on protease inhibitor therapy. AIDS 2001; 15: 329-334.
39. Fuster M, Estrada V, Fernandez-Pinilla MC etal. Smoking cessation in HIV patients: rate of success and associated factors. HIV Med 2009; 10: 614-619.
40. Lloyd-Richardson EE, Stanton CA, Papandonatos GD etal. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction 2009; 104: 1891-1900.
41. Hyland A, Li Q, Bauer JE, Giovino GA, Steger C, Cummings KM. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res 2004; 6 (Suppl 3): S363-S369.
42. Ramón JM, Bou R, Alkiza ME etal. The process of change and sex as predictors of the quitting of tobacco consumption. Arch Bronconeumol 1999; 35: 488-493.
43. Humfleet GL, Hall SM, Delucchi KL, Dilley JW. A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine Tob Res 2013; 15: 1436-1445.
44. Huber M, Ledergerber B, Sauter R etal. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV Med 2012; 13: 387-397.
45. Pacek LR, Latkin C, Crum RM, Stuart EA, Knowlton AR. Interest in quitting and lifetime quit attempts among smokers living with HIV infection. Drug Alcohol Depend 2014; 138: 220-224.
46. Collins RL, Kanouse DE, Gifford AL etal. Changes in health-promoting behavior following diagnosis with HIV: prevalence and correlates in a national probability sample. Health Psychol 2001; 20: 351-360.
47. Gallus S, Muttarak R, Franchi M etal. Why do smokers quit? Eur J Cancer Prev 2012; 22: 96-101.
48. Camaralles-Guillem F, Salvador Llivina T, Ramón Torell JM etal. Consensus on health assistance for smoking control in Spain. Rev Esp Salud Publica 2009; 83: 175-200.
49. EACS. European clinical AIDS society guidelines. Version 7.0. 2013; (October): 0-81. Available at http://eacsociety.org/Guidelines.aspx (accessed 17 Dec 2013).
50. The 2008 PHS guideline update panel L and S. Special articles treating Tobacco use and dependence?: 2008 update U.S. Public Health Service Clinical Practice Guideline Executive Summary. 2008;53 (9): 1217-1222.
51. Ockene JK. Physician-delivered interventions for smoking cessation: strategies for increasing effectiveness. Prev Med 1987; 16: 723-737.
52. Fu M, Martínez-Sánchez JM, López MJ, Nebot M, Raich A, Fernández E. Nicotine dependence and readiness to quit smoking in the Spanish population. Adicciones 2011; 23: 103-109.
53. National Institute of Drug Use. Fagerstrom test for nicotine dependence. 2013. Available at http://datashare.nida.nih.gov/content/fagerstrom-test-nicotine-dependence (accessed 17 Dec 2013).
54. Cropsey KL, Hendricks PS, Jardin B etal. A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav 2013; 38: 2541-2546.
55. Manuel JK, Lum PJ, Hengl NS, Sorensen JL. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care 2013; 25: 820-827.
56. Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr 2012; 61: 208-215.
57. Matthews AK, Conrad M, Kuhns L, Vargas M, King AC. Project Exhale: preliminary evaluation of a tailored smoking cessation treatment for HIV-positive African American smokers. AIDS Patient Care STDS 2013; 27: 22-32.
58. Muramoto ML, Wassum K, Connolly T, Matthews E, Floden L. Helpers program. A pilot test of brief tobacco intervention training in three corporations. Am J Prev Med 2010; 38: S319-S326.
59. Gritz ER, Danysh HE, Fletcher FE etal. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clin Infect Dis 2013; 57: 608-615.
60. Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS 2006; 20: 253-260.
61. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res 2012; 14: 106-110.
62. Nerín I, Novella P, Beamonte A, Gargallo P, Jiménez-Muro A, Marqueta A. Results of smoking cessation therapy in a specialist unit. Arch Bronconeumol 2007; 43: 669-673.
63. Lemmens V, Oenema A, Knut IK, Brug J. Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev 2008; 17: 535-544.
64. Carmody TP, Duncan C, Simon JA etal. Hypnosis for smoking cessation: a randomized trial. Nicotine Tob Res 2008; 10: 811-818.
65. Tahiri M, Mottillo S, Joseph L, Pilote L, Eisenberg MJ. Alternative smoking cessation aids: a meta-analysis of randomized controlled trials. Am J Med 2012; 125: 576-584.
66. Niaura R, Chander G, Hutton H, Stanton C. Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals. Curr HIV/AIDS Rep 2012; 9: 375-384.
67. World Health Organization. International statistical classification of diseases and related health problems, 10 th revision. 2014.
68. Huber M, Ledergerber B, Jaccard R etal. Smoking prevalence, cessation rates and relapse rates in the Swiss HIV Cohort Study (SHCS). J Int AIDS Soc 2010; 13: P231.
69. Olano Espinosa E, Minué Lorenzo C, Ayesta Ayesta FJ. [Pharmacotherapies for nicotine dependence: review of scientific evidence. Spanish Society of Smoking Specialists: recommendations about election and individualization]. Med Clin (Barc) 2011; 136: 79-83.
70. Simpson SA, Nonnemaker JM. New York tobacco control program cessation assistance: costs, benefits, and effectiveness. Int J Environ Res Public Health 2013; 10: 1037-1047.
71. Gyllén P, Andersson BA, Qvarfordt I. Smokeless tobacco or nicotine replacement therapy has no effect on serum immunoglobulin levels. Respir Med 2004; 98: 108-114.
72. Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS Care 2000; 11: 37-44.
73. Cummins D, Trotter G, Moussa M, Turham G. Smoking cessation for clients who are HIV-positive. Nurs Stand 2005; 20: 41-47.
74. Elzi L, Spoerl D, Voggensperger J etal. A smoking cessation programme in HIV-infected individuals: a pilot study. Antivir Ther 2006; 11: 787-795.
75. Pedrol-Clotet E, Deig-Comerma E, Ribell-Bachs M, Vidal-Castell I, García-Rodríguez P, Soler A. [Bupropion use for smoking cessation in HIV-infected patients receiving antiretroviral therapy]. Enferm Infecc Microbiol Clin 2006; 24: 509-511.
76. Tornero C, Mafé C. Varenicline and antiretroviral therapy in patients with HIV. J Acquir Immune Defic Syndr 2009; 52: 656.
77. Cui Q, Robinson L, Elston D etal. Safety and tolerability of varenicline tartrate (Champix®/Chantix®) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care STDS 2012; 26: 12-19.
78. Ferketich AK, Diaz P, Browning KK etal. Safety of varenicline among smokers enrolled in the lung HIV study. Nicotine Tob Res 2013; 15: 247-254.
79. The University of Liverpool. hiv-druginteraction.org. The University of Liverpool. 2014. Available at http://www.hiv-druginteractions.org/Interactions.aspx (accessed 15 Mar 2014).
80. Drugs.com. Drugs interaction checker. 2014; Available at http://www.drugs.com/drug_interactions.html (accessed 15 Mar 2014).
81. Cobb NK, Byron MJ, Abrams DB, Shields PG. Novel nicotine delivery systems and public health: the rise of the 'e-cigarette'. Am J Public Health 2010; 100: 2340-2342.
82. Bullen C, Howe C, Laugesen M etal. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013; 382: 1629-1637.
83. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Voudris V. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of 'vapers' who had achieved complete substitution of smoking. Subst Abuse 2013; 7: 139-146.